Biotech News
Related news
AORTArtivion2026-08-06 20:05 EST
Artivion Reports Second Quarter 2026 Financial Results
CVRXCVRx2026-10-22 20:30 EST
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
PLSEPulse Biosciences2026-10-22 20:05 EST
Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
STIMNeuronetics2026-10-21 12:30 EST
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
SENSSenseonics2026-10-21 12:00 EST
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
IARTIntegra LifeSciences2026-10-06 12:30 EST
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
FEMYFEMASYS2026-08-14 20:05 EST
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
XAIRBeyond Air2026-08-13 11:00 EST
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
SGHTSight Sciences2026-10-21 20:05 EST
Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
OMOutset Medical2026-10-21 20:05 EST
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Artivion
Aortic-Disease Technologies Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease. Surgical Products The company supplies aortic stent grafts, surgical adhesives, mechanical...
Recent company news
AORTArtivion2026-10-22 20:10 EST
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results
AORTArtivion2026-08-06 20:05 EST
Artivion Reports Second Quarter 2026 Financial Results
AORTArtivion2026-07-28 20:10 EST
Artivion to Participate in Upcoming Investor Conferences
AORTArtivion2026-07-23 20:10 EST
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results
AORTArtivion2026-06-29 11:00 EST
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
Stock data
- Close
- 22.90 USD
- Market cap
- 991.26M USD
- Exchange
- NYSE
- Sector
- MedTech
- Location
- United States